All Rankings

Top 100 Biotech Companies 2026

Private biotechnology and genomics companies, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $65.6B.

Showing top 100 matching companies · Ranked by total funding raised · Latest company record update Oct 3, 2026

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

51
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Venture RoundTotal funding$470.0MDec 2024
52
Pathos

Pathos uses multimodal oncology data and AI to simulate clinical trials, identify responsive pati...

Chicago, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$467.0MMay 2025
53
DNA Script

DNA Script develops the SYNTAX platform for enzymatic DNA synthesis, enabling labs to print high-...

Paris, France51–200Biotech, Synthetic Biology
Series CTotal funding$466.5MJan 2022
54
Science.xyz

Clinical-stage medical technology company developing neural-engineering implants and platforms to...

Alameda, United States51–200Biotech, Medtech
Series CTotal funding$457.0MMar 2026
55
Owkin

Owkin builds agentic AI scientists trained on multimodal patient data to help biopharma teams acc...

San Francisco, United States201–500Artificial Intelligence, Biotech
Corporate RoundTotal funding$445.2MJan 2023
56
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series CTotal funding$435.0MJun 2021
57
Ollin Biosciences

Clinical-stage biopharmaceutical company dedicated to developing best-in-disease therapies for vi...

Austin, United States11–50Biotech, Healthcare
Series BTotal funding$430.0MJun 2026
58
AdvanCell

AdvanCell develops targeted alpha radiopharmaceutical therapies, using its vertically integrated ...

Sydney, Australia11–50Biotech, Healthcare
Venture RoundTotal funding$427.0MJul 2026
59
RayzeBio

RayzeBio advances radiopharmaceutical therapies for people with cancer, developing targeted treat...

United StatesBiotech, Healthcare
Series CTotal funding$418.0MSep 2022
60
Benchling

Benchling provides a cloud platform for life sciences R&D, helping scientific teams plan experime...

San Francisco, United States501–1000Biotech, SaaS
Series G+Total funding$412.0MNov 2021
61
Enzene Biosciences

Global biologics CDMO specializing in biosimilars development, manufacturing, and continuous biop...

India501–1000Biotech, Manufacturing
Private EquityTotal funding$412.0MDec 2025
62
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$411.0MJan 2025
63
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate RoundTotal funding$410.0MSep 2024
64
Leyden Labs

Leyden Labs is a clinical-stage biotech developing intranasal antibody sprays that block respirat...

Leiden, Netherlands11–50Biotech, Healthcare
Venture RoundTotal funding$401.6MJun 2026
65
ReCode Therapeutics

ReCode develops precision-delivery genetic medicines, including mRNA and gene correction therapie...

Menlo Park, United States51–200Biotech, Healthcare
Venture RoundTotal funding$390.0MSep 2025
66
Inotrem

French clinical-stage biopharmaceutical company developing TREM-1 inhibition therapies, including...

Paris, France11–50Biotech
Series CTotal funding$379.3MOct 2022
67
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$372.0MJun 2024
68
Tizona Therapeutics

Tizona Therapeutics translates novel scientific insights into first-in-class immunotherapies desi...

South San Francisco, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$370.0MJul 2020
69
Human Longevity

Human Longevity combines genomic science with clinical care to detect disease before symptoms and...

San Diego, United States51–200Biotech
Series BTotal funding$369.8MAug 2024
70
Alentis Therapeutics

Alentis Therapeutics develops anti-Claudin-1 antibodies and antibody-drug conjugates for Claudin-...

Basel, Switzerland51–200Biotech, Drug Discovery
Series DTotal funding$365.9MNov 2024
71
Beacon Therapeutics

Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...

London, United Kingdom51–200Biotech
Series CTotal funding$365.0MJan 2026
72
Windward Bio

Clinical-stage drug development company improving outcomes for people with advanced immunological...

Basel, United States1–10Biotech, Healthcare
Growth EquityTotal funding$365.0MMay 2026
73
DELFI Diagnostics

Develops blood-based liquid biopsy tests using fragmentomics and machine learning to detect and m...

Baltimore, United States51–200Artificial Intelligence, Biotech
Venture RoundTotal funding$364.8MDec 2025
74
Oricell Therapeutics

Oricell develops next-generation cell therapies addressing unmet needs in oncology and immunology...

Shanghai, China51–200Oncology, Therapeutics
Venture RoundTotal funding$364.0MApr 2026
75
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025